Alkermes plc (ALKS) financial statements (2020 and earlier)

Company profile

Business Address CONNAUGHT HOUSE
DUBLIN 4, 00000
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments587539434497535631221
Cash and cash equivalents26126719118618122497
Short-term investments326273242311354407124
Receivables250292234191155152125
Inventory, net of allowances, customer advances and progress billings101909363385143
Inventory101909363385143
Contract with customer, asset58
Prepaid expense and other current assets19
Deferred tax assets 0001 
Other undisclosed current assets545348392641 
Total current assets:998983809791755877409
Noncurrent Assets
Operating lease, right-of-use asset14
Property, plant and equipment341310285265255266288
Long-term investments and receivables218115712226417083
Long-term investments218115712226417083
Intangible assets, net (including goodwill)254284349411472574669
Goodwill93939393939493
Intangible assets, net (excluding goodwill)161191256318379479576
Business combination, contingent consideration, asset2765856355 
Other noncurrent assets151614271435
Prepaid expense and other noncurrent assets22
Deferred tax assets, net 1119 
Other undisclosed noncurrent assets8886984740(9) 
Total noncurrent assets:7608429889361,1011,0441,062
TOTAL ASSETS:1,7581,8251,7971,7261,8561,9211,470
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:35733428620716912177
Accounts payable81405646373218
Accrued liabilities767365536350 
Other undisclosed accounts payable and accrued liabilities199221166107693959
Deferred revenue2
Debt113336677
Due to related parties     37 
Deferred revenue and credits22232
Contract with customer, liability3
Other undisclosed current liabilities     (37) 
Total current liabilities:37034029121223613186
Noncurrent Liabilities
Long-term debt and lease obligation281276278281284351362
Long-term debt, excluding current maturities275276278281284351362
Operating lease, liability7
Liabilities, other than long-term debt38372524214572
Deferred revenue and credits678129
Deferred revenue11
Contract with customer, liability10
Asset retirement obligations     22
Deferred tax liabilities, net   01938
Other liabilities27281917131223
Other undisclosed noncurrent liabilities     (2)(2)
Total noncurrent liabilities:319314303305305394432
Total liabilities:690654594517541524518
Stockholders' equity
Stockholders' equity attributable to parent1,0681,1711,2031,2091,3141,397952
Common stock2222211
Treasury stock, value(118)(109)(89)(73)(59)(32)(5)
Additional paid in capital2,5632,4672,3392,2322,1151,9431,459
Accumulated other comprehensive loss(2)(3)(4)(3)(4)(3)(3)
Accumulated deficit(1,377)(1,185)(1,044)(948)(739)(512)(500)
Total stockholders' equity:1,0681,1711,2031,2091,3141,397952
TOTAL LIABILITIES AND EQUITY:1,7581,8251,7971,7261,8561,9211,470

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2013
Revenues1,0741,094903746628619576
Revenue, net903746628619576
Cost of revenue(183)(176)(155)(132)(142)(216)(170)
Cost of goods and services sold(183)(176)(155)(132)(139)(176)(170)
Gross profit:891918749614486403405
Operating expenses(1,056)(1,017)(897)(822)(710)(490)(323)
Other undisclosed operating income      0
Operating income (loss):(166)(99)(148)(209)(224)(87)82
Nonoperating income (expense)(31)(28)5(6)073(46)
Investment income, nonoperating149541321
Other nonoperating income (expense)(1)(2)(10)(2)0(2)2
Interest and debt expense(10)(2)(12)(2)(13)(13)(69)
Other undisclosed income from continuing operations before equity method investments, income taxes102122131369
Income (loss) from continuing operations before income taxes:(196)(127)(143)(214)(224)(14)35
Income tax expense (benefit)(5)(12)(15)6(3)(16)(10)
Net income (loss) available to common stockholders, diluted:(201)(139)(158)(208)(227)(30)25

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2013
Net income (loss):(201)(139)(158)(208)(227)(30)25
Other comprehensive loss    (0)(8) 
Comprehensive income (loss):(201)(139)(158)(208)(227)(38)25
Other undisclosed comprehensive income (loss), net of tax, attributable to parent21(1)1(0)(6)0
Comprehensive income (loss), net of tax, attributable to parent:(199)(139)(158)(208)(228)(44)25

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: